TA
NBIX icon

Teachers Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Teachers Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$37M Buy
420,145
+127,570
+44% +$10.7M 0.05% 405
2018
Q4 		$20.9M Buy
292,575
+29,574
+11% +$2.83M 0.03% 583
2018
Q3 		$32.3M Sell
263,001
-175
-0.1% -$19.9K 0.04% 508
2018
Q2 		$25.9M Buy
263,176
+20,817
+9% +$1.86M 0.03% 598
2018
Q1 		$20.1M Buy
242,359
+48,964
+25% +$4.13M 0.03% 697
2017
Q4 		$15M Buy
193,395
+94,154
+95% +$6.42M 0.02% 871
2017
Q3 		$6.08M Buy
99,241
+7,691
+8% +$406K 0.01% 1239
2017
Q2 		$4.21M Buy
91,550
+8,903
+11% +$432K 0.01% 1413
2017
Q1 		$3.58M Buy
82,647
+4,360
+6% +$187K 0.01% 1469
2016
Q4 		$3.03M Buy
78,287
+4,668
+6% +$211K ﹤0.01% 1550
2016
Q3 		$3.73M Buy
73,619
+1,166
+2% +$58.1K 0.01% 1375
2016
Q2 		$3.29M Sell
72,453
-152,760
-68% -$7.03M 0.01% 1371
2016
Q1 		$8.91M Sell
225,213
-113,957
-34% -$4.52M 0.02% 913
2015
Q4 		$19.2M Buy
339,170
+5,746
+2% +$292K 0.04% 552
2015
Q3 		$13.3M Sell
333,424
-16
-0% -$773 0.03% 716
2015
Q2 		$15.9M Buy
333,440
+12,739
+4% +$540K 0.03% 670
2015
Q1 		$12.7M Buy
320,701
+216,747
+209% +$7.75M 0.02% 788
2014
Q4 		$2.32M Hold
103,954
– – ﹤0.01% 1526
2014
Q3 		$1.63M Sell
103,954
-3,800
-4% -$56.8K ﹤0.01% 1734
2014
Q2 		$1.6M Buy
107,754
+9,599
+10% +$135K ﹤0.01% 1784
2014
Q1 		$1.58M Buy
98,155
+2,330
+2% +$39.9K ﹤0.01% 1747
2013
Q4 		$895K Buy
95,825
+3,880
+4% +$37.9K ﹤0.01% 2063
2013
Q3 		$1.04M Buy
91,945
+3,532
+4% +$48.6K ﹤0.01% 1902
2013
Q2 		$1.18M Buy
+88,413
New +$1.09M ﹤0.01% 1756

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's NBIX Position: Q1 2019 in Review

Teachers Advisors increased its Neurocrine Biosciences (NBIX) stake by 44% in Q1 2019, buying an estimated $10.7M and bringing the position to 420,145 shares worth $37M. The position accounts for 0.05% of the portfolio, ranked #405.

Teachers Advisors first reported a position in NBIX in Q2 2013 and has held it in 24 quarters since. 325 funds tracked by Wall St. Rank hold NBIX as of Q1 2019.

  • Teachers Advisors held 420,145 shares of Neurocrine Biosciences worth $37M as of Q1 2019.
  • Teachers Advisors bought 127,570 Neurocrine Biosciences shares in Q1 2019, an estimated $10.7M.
  • Neurocrine Biosciences made up 0.05% of Teachers Advisors's portfolio in Q1 2019, its #405 holding.
  • Teachers Advisors first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 24 quarters since.
  • 325 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.